BCAL DIAGNOSTICS LIMITEDBCAL DIAGNOSTICS LIMITEDBCAL DIAGNOSTICS LIMITED

BCAL DIAGNOSTICS LIMITED

No trades
See on Supercharts

BDX fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

BCAL Diagnostics Ltd. develops screening tests for the early detection of breast cancer. It also associated lipids, biomarker blood test that is used for prevention, screening and monitoring. The company was founded by Jayne Shaw and Ron Philips in 2010 and is headquartered in Sydney, Australia.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
BDX has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company